6 completed. 6 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 6 | Completed 6 |
Follow ixabepilone: new trials by email Literature Review of ixabepilone trials Research Report on ixabepilone
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of Etirinotecan Pegol (NKTR-102) Versus Treatment of Physician's Choice (TPC) in Patients With Metastatic Breast Cancer Who Have Stable Brain Metastases and Have Been Previously Treated With an Anthracycline, a Taxane, and Capecitabine NKTR-102, Eribulin, Ixabepilone - Metastasis, Breast Cancer | Phase 3 | Completed | Nektar Therapeutics | 178 | 2016-11-01 | 2023-04-14 |
| A Randomized Trial of Ixempra Versus Taxol in Adjuvant Therapy of Triple Negative Breast Cancer Doxorubicin, Cyclophosphamide, Ixabepilone (Ixempra) - Breast Cancer | Phase 3 | Completed | SCRI Development Innovations, LLC | 614 | 2008-12-01 | 2017-07-02 |
| Paclitaxel, Nab-paclitaxel, or Ixabepilone With or Without Bevacizumab in Treating Patients With Stage IIIC or Stage IV Breast Cancer Bevacizumab, Ixabepilone, Laboratory Biomarker Analysis - Estrogen Receptor Negative, Estrogen Receptor Positive | Phase 3 | Completed | National Cancer Institute (NCI) | 799 | 2008-10-13 | 2026-06-23 |
| Safety and Efficacy Comparison of Docetaxel and Ixabepilone in Non Metastatic Poor Prognosis Breast Cancer cyclophosphamide, Docetaxel, epirubicin hydrochloride - Breast Cancer | Phase 3 | Completed | UNICANCER | 762 | 2007-09-01 | 2024-02-21 |
| Epothilone (Ixabepilone) Plus Capecitabine Versus Capecitabine Alone in Patients With Advanced Breast Cancer Ixabepilone + Capecitabine, Capecitabine - Cancer, Breast Cancer | Phase 3 | Completed | R-Pharm | 1221 | 2003-11-01 | 2020-11-02 |
| Novel Epothilone Plus Capecitabine Versus Capecitabine Alone in Patients With Advanced Breast Cancer Ixabepilone + Capecitabine, Capecitabine - Breast Cancer, Metastases | Phase 3 | Completed | R-Pharm | 752 | 2003-09-01 | 2020-11-02 |
Breast Neoplasms (6) · Neoplasm Metastasis (2) · Carcinoma (1) · Neoplasms (1)
R-Pharm (2) · National Cancer Institute (NCI) (1) · Nektar Therapeutics (1) · SCRI Development Innovations, LLC (1) · UNICANCER (1)
United States (6) · Belgium (4) · France (4) · Canada (3) · Italy (3) · Spain (3) · United Kingdom (3) · Argentina (2) · Australia (2) · Brazil (2) · China (2) · Germany (2) · Greece (2) · Israel (2) · Portugal (2)
Denise A Yardley, M.D. (1) · Hope S Rugo (1) · Mario Campone, MD (1)
PMID 21128114, PMID 21937232, PMID 24472478, PMID 17968020, PMID 26056183, PMID 28620884, PMID 29522361, PMID 31074641, PMID 34616010, PMID 35552364, PMID 39169033
U10CA031946 (1), U10CA180821 (1)